Climb Bio, Inc. 8-K

What Happened On May 7, 2026, Climb Bio, Inc. announced its quarterly financial results for the period ended March 31, 2026 via a press release. The company filed a Form 8-K under Item 2.02 (Results of Operations and Financial Condition) to disclose the announcement; the press release is attached as Exhibit 99.1. The filing was signed by President and CEO Aoife Brennan, M.B., Ch.B.

Key Details

• Filing date: May 7, 2026; quarter covered: quarter ended March 31, 2026.
• Disclosure type: Item 2.02 — Results of Operations and Financial Condition (press release attached as Exhibit 99.1).
• The 8-K incorporates the press release by reference; readers should consult Exhibit 99.1 for the specific earnings, revenue, or other financial figures.
• Form signed by Aoife Brennan, President and Chief Executive Officer.

Why It Matters This 8-K signals Climb Bio’s public release of its latest quarterly results (earnings, revenue and other financial metrics), which can affect investor decisions and the stock price. The Form itself does not reproduce the numbers in-line; investors should read the attached press release (Exhibit 99.1) or the company’s investor materials for full details on revenue, net results, cash position, or guidance. No other material events (e.g., executive departures or mergers) were reported in this filing.